Tadalafil: Une pharmacologie uniqueLECHAT, P; PINTON, P.Progrès en urologie (Paris). 2004, Vol 14, pp 18-21, issn 1166-7087, 4 p., SUP1Conference Paper

Determination of Tadalafil in Pure Powder and Tablet Dosage Form by High-Performance Liquid ChromatographyBAROT, Tushar G; PATEL, Popatbhai K.Journal of AOAC International. 2010, Vol 93, Num 2, pp 516-522, issn 1060-3271, 7 p.Article

Time course of the interaction between tadalafil and nitratesKLONER, Robert A; HUTTER, Adolph M; EMMICK, Jeffrey T et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 10, pp 1855-1860, issn 0735-1097, 6 p.Article

Woundtable discussion: Tadalafil study groupKLONER, Robert A; BRINDIS, Ralph G; CHEITLIN, Melvin D et al.The American journal of cardiology. 2003, Vol 92, Num 9A, pp 58M-65M, issn 0002-9149Conference Paper

Tadalafil Prevents Acute Heart Failure with Reduced Ejection Fraction in MiceSALLOUM, Fadi N; CHAU, Vinh Q; HOKE, Nicholas N et al.Cardiovascular drugs and therapy. 2014, Vol 28, Num 6, pp 493-500, issn 0920-3206, 8 p.Article

Ambrisentan and Tadalafil Synergistically Relax Endothelin-Induced Contraction of Rat Pulmonary ArteriesFAQUAN LIANG; SUYA YANG; LINA YAO et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 59, Num 3, pp 705-711, issn 0194-911X, 7 p.Article

Comparison of efficacy for erectile function and lower urinary tract symptoms of tadalafil 20 mg on-demand and 5 mg once daily in patients with erectile dysfunctionKANG, D. H; LEE, J. Y; CHUNG, J. H et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 8, pp 813-820, issn 1368-5031, 8 p.Article

Fingerprinting of sildenafil citrate and tadalafil tablets in pharmaceutical formulations via X-ray fluorescence (XRF) spectrometryORTIZ, Rafael S; MARIOTTI, Kristiane C; SCHWAB, Nicolas V et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 58, pp 7-11, issn 0731-7085, 5 p.Article

Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in ratsRASHID, M; KOTWANI, A; FAHIM, M et al.Human & experimental toxicology. 2012, Vol 31, Num 6, pp 626-636, issn 0960-3271, 11 p.Article

Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogsOCHIANA, Stefan O; GUSTAFSON, Alden; BLAND, Nicholas D et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 7, pp 2582-2584, issn 0960-894X, 3 p.Article

Tadalafil: In the Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia with or without Erectile DysfunctionCURRAN, Monique P.Drugs & aging. 2012, Vol 29, Num 9, pp 771-781, issn 1170-229X, 11 p.Article

Dysfonction érectile: traitements conservateurs et nouvelles approches = Erectile dysfunction: conservative treatment and new approachesHENRIET, B; ROUMEGUERE, T.Revue médicale de Bruxelles. 2012, Vol 33, Num 3, pp 146-152, issn 0035-3639, 7 p.Article

Brachial artery flow mediated assessment: A tool to predict the response to chronic PDE5 inhibition with tadalafil in patients with erectile dysfunctionMANCINI, Mario; GUAZZI, Marco; BIANCO, Elisabetta et al.International journal of cardiology. 2011, Vol 146, Num 3, pp 471-472, issn 0167-5273, 2 p.Article

Development and validation of a GC/MS method for the determination of tadalafil in whole bloodNIKOLAOU, Panagiota; PAPOUTSIS, Ioannis; ATHANASELIS, Sotirios et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 56, Num 3, pp 577-581, issn 0731-7085, 5 p.Article

The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pupsBAEK, Sang-Bin; BAHN, Geonho; KIM, Chang-Ju et al.Neuroscience letters. 2011, Vol 488, Num 1, pp 26-30, issn 0304-3940, 5 p.Article

Focus on Phosphodiesterase Inhibitors for the Treatment of Erectile Dysfunction in Older MenLEE, Mary.Clinical therapeutics. 2011, Vol 33, Num 11, pp 1590-1608, issn 0149-2918, 19 p.Article

Effects of Tadalafil on Platelets and Endothelium in Patients With Erectile Dysfunction and Cardiovascular Risk Factors: A Pilot StudyDE BON, Emiliano; BONANNI, Guglielmo; SAGGIORATO, Graziella et al.Angiology. 2010, Vol 61, Num 6, pp 602-606, issn 0003-3197, 5 p.Article

Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cellsHAIDER, Husnain Kh; LEE, Yun-Jung; SHUJIA JIANG et al.American journal of physiology. Heart and circulatory physiology. 2010, Vol 68, Num 5, issn 0363-6135, H1395-H1404Article

Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometryYING ZHANG; ZHIQIANG HUANG; LI DING et al.Journal of separation science (Print). 2010, Vol 33, Num 14, pp 2109-2114, issn 1615-9306, 6 p.Article

The identification of (―)-trans-tadalafil, tadalafil, and sildenafil in counterfeit Cialis^® and the optical purity of tadalafil stereoisomersVENHUIS, B. J; ZOMER, G; VREDENBREGT, M. J et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 51, Num 3, pp 723-727, issn 0731-7085, 5 p.Article

Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical TrialDMOCHOWSKI, Roger; ROEHRBORN, Claus; KLISE, Suzanne et al.The Journal of urology. 2010, Vol 183, Num 3, pp 1092-1097, issn 0022-5347, 6 p.Article

Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trialSHENOY, Padmanabha D; KUMAR, Sudeep; JHA, Lalan K et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 12, pp 2420-2428, issn 1462-0324, 9 p.Article

Phosphodiesterase Type 5 Inhibitors: Unmet Needs : Phosphodieterase-5 Inhibitors and their Use in the Treatment of Urological ConditionsHATZIMOURATIDIS, K; HATZICHRISTOU, D. G.Current pharmaceutical design (Print). 2009, Vol 15, Num 30, pp 3476-3485, issn 1381-6128, 10 p.Article

Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic SclerosisSCHIOPU, Elena; HSU, Vivien M; IMPENS, Ann J et al.Journal of rheumatology. 2009, Vol 36, Num 10, pp 2264-2268, issn 0315-162X, 5 p.Article

Tadalafil and vardenafil vs sildenafil : a review of patient-preference studiesMIRONE, Vincenzo; FUSCO, Ferdinando; ROSSI, Andrea et al.BJU international (Papier). 2009, Vol 103, Num 9, pp 1212-1217, issn 1464-4096, 6 p.Article